SCHEMBL5782310

SCHEMBL5782310

COc1ccc(-c2cccc(Nc3nccc(-c4sc(N)nc4-c4ccccc4)n3)c2)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 2/20 0.50
CDK9 P50750 2/20 0.50
PIK3CG P48736 6/20 0.49
GSK3B P49841 3/20 0.49
CAMKK2 Q96RR4 3/20 0.49
MAPK8 P45983 2/20 0.49
CDK5 Q00535 3/20 0.48
CDK4 P11802 2/20 0.47
CDK2 P24941 2/20 0.47
CDK5R1 Q15078 2/20 0.47
AURKA O14965 1/20 0.47
CCNB2 O95067 1/20 0.47
CCNE2 O96020 1/20 0.47
ABL1 P00519 1/20 0.47
CDK1 P06493 1/20 0.47
CCNB1 P14635 1/20 0.47
CCNA2 P20248 1/20 0.47
CCND1 P24385 1/20 0.47
CCNE1 P24864 1/20 0.47
ABL2 P42684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5781821 0.87 PIK3CG (0.60) CCNT1CDK9PIK3CGGSK3BMAPK8
SCHEMBL5780635 0.83 KCNH2 (0.57) CCNT1CDK9GSK3BMAPK8CDK5
SCHEMBL5782012 0.81 ABL1 (0.63) CCNT1CDK9PIK3CGGSK3BCAMKK2
SCHEMBL5780393 0.81 CAMK2D (0.62) CCNT1CDK9GSK3BCDK5CDK4
SCHEMBL5781152 0.81 CDK4 (0.59) CCNT1CDK9PIK3CGGSK3BCAMKK2
SCHEMBL5779741 0.81 CCNT1 (0.53) CCNT1CDK9PIK3CGGSK3BCAMKK2
SCHEMBL5782345 0.81 PIK3CG (0.70) CCNT1CDK9PIK3CGGSK3BMAPK8
SCHEMBL5780335 0.79 CCNT1 (0.51) CCNT1CDK9PIK3CGGSK3BCAMKK2
SCHEMBL5781584 0.79 CCNT1 (0.54) CCNT1CDK9PIK3CGGSK3BCAMKK2
SCHEMBL5779921 0.79 CCNT1 (0.51) CCNT1CDK9PIK3CGGSK3BCAMKK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105517-B2 Thiazolyl substituted aminopyrimidines as plant protection agents SYNGENTA CROP PROTECTION, INC. (US) 2006-09-12 US disclosed
EP-1434776-B1 THIAZOLYL SUBSTITUTED AMINOPYRIMIDINES AS PLANT PROTECTION AGENTS SYNGENTA PARTICIPATIONS AG (CH) 2006-06-28 EP disclosed
US-20050038059-A1 Thiazolyl substituted aminopyrimidines as plant protection agents SYNGENTA CROP PROTECTION, INC. 2005-02-17 US disclosed
EP-1434776-A1 THIAZOLYL SUBSTITUTED AMINOPYRIMIDINES AS PLANT PROTECTION AGENTS Syngenta Participations AG (CH) 2004-07-07 EP disclosed
WO-2003029249-A1 THIAZOLYL SUBSTITUTED AMINOPYRIMIDINES AS PLANT PROTECTION AGENTS SYNGENTA PARTICIPATIONS AG (CH) 2003-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038059-A1 Thiazolyl substituted aminopyrimidines as plant protection agents RARS2, CYP4X1, QDPR CCNT1 653/4885CDK9 1570/4885PIK3CG 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.